共 42 条
[11]
实用抗菌药物学[M]. 上海科学技术出版社 , 戴自英等主编, 1998
[12]
New chimeric advanced Drug Delivery nano Systems （chi-aDDnSs） as doxorubicin carriers[J] . Konstantinos Gardikis,Chrisiida Tsimplouli,Konstantinos Dimas,Maria Micha-Screttas,Costas Demetzos.International Journal of Pharmaceutics . 2010 (1)
[13]
High azithromycin loading powders for inhalation and their in vivo evaluation in rats[J] . Yu Zhang,Xiaoli Wang,Xia Lin,Xiaoliang Liu,Bin Tian,Xing Tang.International Journal of Pharmaceutics . 2010 (1)
[14]
Application of melt granulation technology to enhance stability of a moisture sensitive immediate-release drug product
[J].
INTERNATIONAL JOURNAL OF PHARMACEUTICS,
2009, 381 (01)
:56-61
Kowalski, James
;
Kalb, Oskar
;
Joshi, Yatindra M.
;
Serajuddin, Abu T. M.
.
[15]
T lymphocytes as potential therapeutic drug carrier for cancer treatment[J] . Ute Steinfeld,Christine Pauli,Nikolas Kaltz,Christian Bergemann,Hyeck-Hee Lee.International Journal of Pharmaceutics . 2006 (1)
[16]
Pharmacokinetics of doxorubicin administered i.v. as Myocet （TLC D-99;liposome-encapsulated doxorubicin citrate） compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer[J] . Christine E. Swenson,Lois E. Bolcsak,Gerald Batist,Troy H. Guthrie,Katherine H. Tkaczuk,Harold Boxenbaum,Lauri Welles,Shein-Chung Chow,Rupinder Bhamra,Philip Chaikin.Anti-Cancer Drugs . 2003 (3)
[17]
Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin
[J].
CANCER,
2001, 92 (07)
:1936-1942
Fabel, K
;
Dietrich, J
;
Hau, P
;
Wismeth, C
;
Winner, B
;
Przywara, S
;
Steinbrecher, A
;
Ullrich, W
;
Bogdahn, U
.
[18]
Early evaluation of liposomal daunorubicin （DaunoXome?, Nexstar） in the treatment of relapsed and refractory lymphoma[J] . Deborah S. Richardson,Stephen M. Kelsey,Stephen A. Johnson,Mary Tighe,James D. Cavenagh,Adrian C. Newland.Investigational New Drugs . 1997 (3)